Test Bank: Pharmacotherapeutics for Advanced
p p p p
Practice Nurse Prescribers, 5th Edition, Teri Moser
p p p p p p p
Woo, Marylou
p p
Pharmacotherapeutics for Advanced p p
Practice Nurse Prescribers 5th
p p p p
EditionWoo Robinson Test Bank
p p p p p
,Test Bank: Pharmacotherapeutics for Advanced
p p p p
Practice Nurse Prescribers, 5th Edition, Teri Moser
p p p p p p p
Woo, Marylou
p p
Pharmacotherapeutics pfor pAdvanced pPractice pNurse pPrescribers p5th pEdition pWoo pRobinson pTest pBank
Chapter p1. pThe pRole pof pthe pNurse
p PractitionerpMultiple pChoice
Identify pthe pchoice pthat pbest pcompletes pthe pstatement por panswers pthe pquestion.
p ppp 1. pNurse ppractitioner pprescriptive pauthority pis pregulated pby:
1. The pNational pCouncil pof pState pBoards pof pNursing
2. The pU.S. pDrug pEnforcement pAdministration
3. The pState pBoard pof pNursing pfor peach pstate
4. The pState pBoard pof pPharmacy
p ppp 2. pThe pbenefits pto pthe ppatient pof phaving pan pAdvanced pPractice pRegistered pNurse p(APRN)
pprescriberpinclude:
1. Nurses pknow pmore pabout pPharmacology pthan pother pprescribers pbecause pthey
ptake pitpboth pin ptheir pbasic pnursing pprogram pand pin ptheir pAPRN pprogram.
2. Nurses pcare pfor pthe ppatient pfrom pa pholistic papproach pand pinclude pthe
ppatient pinpdecision pmaking pregarding ptheir pcare.
3. APRNs pare pless plikely pto pprescribe pnarcotics pand pother pcontrolled psubstances.
4. APRNs pare pable pto pprescribe pindependently pin pall pstates, pwhereas pa
pphysician’spassistant pneeds pto phave pa pphysician psupervising ptheir ppractice.
p ppp 3. pClinical pjudgment pin pprescribing p includes:
1. Factoring pin pthe pcost pto pthe ppatient pof pthe pmedication pprescribed
2. Always pprescribing pthe pnewest pmedication pavailable pfor pthe pdisease pprocess
3. Handing pout pdrug psamples pto ppoor ppatients
4. Prescribing pall pgeneric pmedications pto pcut pcosts
p ppp 4. pCriteria pfor pchoosing pan peffective pdrug pfor pa pdisorder p include:
1. Asking pthe ppatient pwhat pdrug pthey pthink pwould pwork pbest pfor pthem
2. Consulting pnationally precognized pguidelines pfor pdisease pmanagement
3. Prescribing pmedications pthat pare pavailable pas psamples pbefore pwriting pa pprescription
4. Following pU.S. pDrug pEnforcement pAdministration pguidelines pfor pprescribing
p ppp 5. pNurse ppractitioner ppractice pmay pthrive punder phealth-care preform pbecause p of:
1. The pdemonstrated pability pof pnurse ppractitioners pto pcontrol pcosts pand pimprove
ppatientpoutcomes
2. The pfact pthat pnurse ppractitioners pwill pbe pable pto ppractice pindependently
3. The pfact pthat pnurse ppractitioners pwill phave pfull preimbursement punder phealth-
carepreform
4. The pability pto pshift paccountability pfor pMedicaid pto pthe pstate plevel
,Test Bank: Pharmacotherapeutics for Advanced
p p p p
Practice Nurse Prescribers, 5th Edition, Teri Moser
p p p p p p p
Woo, Marylou
p p
, Test Bank: Pharmacotherapeutics for Advanced
p p p p
Practice Nurse Prescribers, 5th Edition, Teri Moser
p p p p p p p
Woo, Marylou
p p
Chapter p1. pThe pRole pof pthe pNurse
pPractitionerpAnswer pSection
MULTIPLE pCHOICE
1. ANS: p p p 3 PTS: p 1
2. ANS: p p p 2 PTS: p 1
3. ANS: p p p 1 PTS: p 1
4. ANS: p p p 2 PTS: p 1
5. ANS: p p p 1 PTS: p 1
Chapter p2. pReview pof pBasic pPrinciples pof
p PharmacologypMultiple pChoice
Identify pthe pchoice pthat pbest pcompletes pthe pstatement por panswers pthe pquestion.
p ppp 1. pA ppatient’s pnutritional pintake pand plaboratory presults preflect phypoalbuminemia. pThis pis
pcritical ptopprescribing pbecause:
1. Distribution pof pdrugs pto ptarget ptissue pmay pbe paffected.
2. The psolubility pof pthe pdrug pwill pnot pmatch pthe psite pof pabsorption.
3. There pwill pbe pless pfree pdrug pavailable pto pgenerate pan peffect.
4. Drugs pbound pto palbumin pare preadily pexcreted pby pthe pkidneys.
p ppp 2. pDrugs pthat phave pa psignificant pfirst-pass p effect:
1. Must pbe pgiven pby pthe penteral p(oral) proute ponly
2. Bypass pthe phepatic pcirculation
3. Are prapidly pmetabolized pby pthe pliver pand pmay phave plittle pif pany pdesired paction
4. Are pconverted pby pthe pliver pto pmore pactive pand pfat-soluble pforms
p ppp 3. pThe proute pof pexcretion pof pa pvolatile pdrug pwill plikely pbe pthe:
1. Kidneys
2. Lungs
3. Bile pand pfeces
4. Skin
p ppp 4. pMedroxyprogesterone p(Depo pProvera) pis pprescribed pintramuscularly p(IM) pto pcreate pa
pstoragepreservoir pof pthe pdrug. pStorage preservoirs:
1. Assure pthat pthe pdrug pwill preach pits pintended ptarget ptissue
2. Are pthe preason pfor pgiving ploading pdoses
3. Increase pthe plength pof ptime pa pdrug pis pavailable pand pactive
4. Are pmost pcommon pin pcollagen ptissues
p ppp 5. pThe pNP pchooses pto pgive pcephalexin pevery p8 phours pbased pon pknowledge pof pthe pdrug’s:
1. Propensity pto pgo pto pthe ptarget preceptor
2. Biological phalf-life
3. Pharmacodynamics
4. Safety pand pside peffects
p p p p
Practice Nurse Prescribers, 5th Edition, Teri Moser
p p p p p p p
Woo, Marylou
p p
Pharmacotherapeutics for Advanced p p
Practice Nurse Prescribers 5th
p p p p
EditionWoo Robinson Test Bank
p p p p p
,Test Bank: Pharmacotherapeutics for Advanced
p p p p
Practice Nurse Prescribers, 5th Edition, Teri Moser
p p p p p p p
Woo, Marylou
p p
Pharmacotherapeutics pfor pAdvanced pPractice pNurse pPrescribers p5th pEdition pWoo pRobinson pTest pBank
Chapter p1. pThe pRole pof pthe pNurse
p PractitionerpMultiple pChoice
Identify pthe pchoice pthat pbest pcompletes pthe pstatement por panswers pthe pquestion.
p ppp 1. pNurse ppractitioner pprescriptive pauthority pis pregulated pby:
1. The pNational pCouncil pof pState pBoards pof pNursing
2. The pU.S. pDrug pEnforcement pAdministration
3. The pState pBoard pof pNursing pfor peach pstate
4. The pState pBoard pof pPharmacy
p ppp 2. pThe pbenefits pto pthe ppatient pof phaving pan pAdvanced pPractice pRegistered pNurse p(APRN)
pprescriberpinclude:
1. Nurses pknow pmore pabout pPharmacology pthan pother pprescribers pbecause pthey
ptake pitpboth pin ptheir pbasic pnursing pprogram pand pin ptheir pAPRN pprogram.
2. Nurses pcare pfor pthe ppatient pfrom pa pholistic papproach pand pinclude pthe
ppatient pinpdecision pmaking pregarding ptheir pcare.
3. APRNs pare pless plikely pto pprescribe pnarcotics pand pother pcontrolled psubstances.
4. APRNs pare pable pto pprescribe pindependently pin pall pstates, pwhereas pa
pphysician’spassistant pneeds pto phave pa pphysician psupervising ptheir ppractice.
p ppp 3. pClinical pjudgment pin pprescribing p includes:
1. Factoring pin pthe pcost pto pthe ppatient pof pthe pmedication pprescribed
2. Always pprescribing pthe pnewest pmedication pavailable pfor pthe pdisease pprocess
3. Handing pout pdrug psamples pto ppoor ppatients
4. Prescribing pall pgeneric pmedications pto pcut pcosts
p ppp 4. pCriteria pfor pchoosing pan peffective pdrug pfor pa pdisorder p include:
1. Asking pthe ppatient pwhat pdrug pthey pthink pwould pwork pbest pfor pthem
2. Consulting pnationally precognized pguidelines pfor pdisease pmanagement
3. Prescribing pmedications pthat pare pavailable pas psamples pbefore pwriting pa pprescription
4. Following pU.S. pDrug pEnforcement pAdministration pguidelines pfor pprescribing
p ppp 5. pNurse ppractitioner ppractice pmay pthrive punder phealth-care preform pbecause p of:
1. The pdemonstrated pability pof pnurse ppractitioners pto pcontrol pcosts pand pimprove
ppatientpoutcomes
2. The pfact pthat pnurse ppractitioners pwill pbe pable pto ppractice pindependently
3. The pfact pthat pnurse ppractitioners pwill phave pfull preimbursement punder phealth-
carepreform
4. The pability pto pshift paccountability pfor pMedicaid pto pthe pstate plevel
,Test Bank: Pharmacotherapeutics for Advanced
p p p p
Practice Nurse Prescribers, 5th Edition, Teri Moser
p p p p p p p
Woo, Marylou
p p
, Test Bank: Pharmacotherapeutics for Advanced
p p p p
Practice Nurse Prescribers, 5th Edition, Teri Moser
p p p p p p p
Woo, Marylou
p p
Chapter p1. pThe pRole pof pthe pNurse
pPractitionerpAnswer pSection
MULTIPLE pCHOICE
1. ANS: p p p 3 PTS: p 1
2. ANS: p p p 2 PTS: p 1
3. ANS: p p p 1 PTS: p 1
4. ANS: p p p 2 PTS: p 1
5. ANS: p p p 1 PTS: p 1
Chapter p2. pReview pof pBasic pPrinciples pof
p PharmacologypMultiple pChoice
Identify pthe pchoice pthat pbest pcompletes pthe pstatement por panswers pthe pquestion.
p ppp 1. pA ppatient’s pnutritional pintake pand plaboratory presults preflect phypoalbuminemia. pThis pis
pcritical ptopprescribing pbecause:
1. Distribution pof pdrugs pto ptarget ptissue pmay pbe paffected.
2. The psolubility pof pthe pdrug pwill pnot pmatch pthe psite pof pabsorption.
3. There pwill pbe pless pfree pdrug pavailable pto pgenerate pan peffect.
4. Drugs pbound pto palbumin pare preadily pexcreted pby pthe pkidneys.
p ppp 2. pDrugs pthat phave pa psignificant pfirst-pass p effect:
1. Must pbe pgiven pby pthe penteral p(oral) proute ponly
2. Bypass pthe phepatic pcirculation
3. Are prapidly pmetabolized pby pthe pliver pand pmay phave plittle pif pany pdesired paction
4. Are pconverted pby pthe pliver pto pmore pactive pand pfat-soluble pforms
p ppp 3. pThe proute pof pexcretion pof pa pvolatile pdrug pwill plikely pbe pthe:
1. Kidneys
2. Lungs
3. Bile pand pfeces
4. Skin
p ppp 4. pMedroxyprogesterone p(Depo pProvera) pis pprescribed pintramuscularly p(IM) pto pcreate pa
pstoragepreservoir pof pthe pdrug. pStorage preservoirs:
1. Assure pthat pthe pdrug pwill preach pits pintended ptarget ptissue
2. Are pthe preason pfor pgiving ploading pdoses
3. Increase pthe plength pof ptime pa pdrug pis pavailable pand pactive
4. Are pmost pcommon pin pcollagen ptissues
p ppp 5. pThe pNP pchooses pto pgive pcephalexin pevery p8 phours pbased pon pknowledge pof pthe pdrug’s:
1. Propensity pto pgo pto pthe ptarget preceptor
2. Biological phalf-life
3. Pharmacodynamics
4. Safety pand pside peffects
